Evaluation of Dihydrotestosterone Levels and Total Testosterone to Dihydrotestosterone Ratio with Clinical Symptoms and Metabolic Parameters in Patients with Polycystic Ovary Syndrome
November 2025
in “
BMC Endocrine Disorders
”
Research cited in this study
5 / 5 resultsresearch Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
research Total Testosterone to Dihydrotestosterone Ratio Assessed by LC-MS/MS Predicts a Worse Metabolic Profile Not Only in PCOS Patients
A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.
research Prevalence of Androgenic Alopecia in Patients with Polycystic Ovary Syndrome and Characterization of Associated Clinical and Biochemical Features
Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.
research Assessment of the Usefulness of Dihydrotestosterone in the Diagnostics of Patients with Androgenetic Alopecia
DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.
research Metabolic Features of the Reproductive Phenotypes of Polycystic Ovary Syndrome
Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.